# To Assess Continued Safety of and Adherence to the Dapivirine (25 mg) Vaginal Ring-004 in Healthy, HIV-negative Women

> **NCT02862171** · PHASE3 · COMPLETED · sponsor: **International Partnership for Microbicides, Inc.** · enrollment: 941 (actual)

## Conditions studied

- HIV Prevention

## Interventions

- **DRUG:** Dapivirine Vaginal Ring-004

## Key facts

- **NCT ID:** NCT02862171
- **Lead sponsor:** International Partnership for Microbicides, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2016-07-12
- **Primary completion:** 2019-01-11
- **Final completion:** 2019-01-11
- **Target enrollment:** 941 (ACTUAL)
- **Last updated:** 2022-10-25


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02862171

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02862171, "To Assess Continued Safety of and Adherence to the Dapivirine (25 mg) Vaginal Ring-004 in Healthy, HIV-negative Women". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT02862171. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*